CIPLA FDA Approval ANDA 210174

ANDA 210174

CIPLA

FDA Drug Application

Application #210174

Application Sponsors

ANDA 210174CIPLA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUSEQ 4MG BASE/100ML0ZOLEDRONIC ACIDZOLEDRONIC ACID

FDA Submissions

UNKNOWN; ORIG1AP2017-10-27STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

PUNISKA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210174
            [companyName] => PUNISKA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ZOLEDRONIC ACID","activeIngredients":"ZOLEDRONIC ACID","strength":"EQ 4MG BASE\/100ML","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/27\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"02\/21\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-02-21
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.